logo

We are kicking off #MensHealthWeek with a series of local events and activities in Lismore NSW

We are kicking off #MensHealthWeek with a series of local events and activities in Lismore NSW.  Watch our video here #itshealthytotalk

Posted in Andrology Australia, Community health, Health promotion, International Men's Health Week, Men's health, Men's health events |

Invitation to a public lecture on Prostate Cancer

You are invited to a public lecture at a Monash University, Department of Surgery, Central Clinical School, public lecture on The Australian Revolution in Prostate Cancer Diagnosis. 

Speaker: Associate Professor Jeremy Grummet MBBS, MS, FRACS is a consultant Urologist and Director of Clinical Research of the Urology Unit at Alfred Health, overseeing multiple currently recruiting clinical trials.  He will be giving a public lecture on the latest research and treatments, 5.30pm (Drinks & Canapés) 6.00 pm (Lecture) Thursday 26th April at the Alfred Medical Research and Education Centre.  All welcome.

RSVP link

Event description: https://www.monash.edu/medicine/ccs/headlines/events-calendar/2018-surgery-public-lecture

Posted in Andrology Australia, Community health, Health promotion, Men's health, Men's health events, Research and Evaluation, Training and Education |

Andrology Australia congratulates Professor David Handelsman, a recipient of the Officer (AO)

Andrology Australia congratulates Professor David Handelsman, a recipient of the Officer (AO) in the General Division of the Order of Australia in the 2018 Australia Day Honours. David was cited for his “distinguished service to medicine, particularly to reproductive endocrinology and andrology, as a clinician, author and researcher, to the science of doping in sport, and to medical education.” David has been a member of the Andrology Australia Advisory Board and several of our specialised reference groups since 2000.

Posted in Uncategorized |

Participants required – Clinical study about non-prescribed androgens

The Andrology Department at Concord Repatriation General Hospital in Sydney is recruiting for a study looking at reproductive and cardiac (heart) health of men using non-prescribed androgens – “anabolic steroids’

There are few good studies measuring the impact of androgen abuse on heart structure and function, and whether these effects are reversible once you stop taking the steroids. This study aims to answer some of these questions.

The study needs men between 18 and 50 years of age, exercising regularly (at least 3 times/week) and current or past users of non-prescribed androgens. Participants must be able to travel to Concord Hospital in Sydney.

You will need to come to the hospital for either a single visit over 4 hours or two visits of 2 hours each. At the visit serum and urine hormones will be measured as well as biochemistry, semen analysis, testicular ultrasound, body composition scans, ECG, ECHO and CT calcium scores.

The study is cost-free and you may be given the Hospital lab test results. However, there is no payment for participating.

If you are interested in finding our more about the study, please contact the Concord Hospital Andrology Department on (02) 9767 7222 or email androgens.study@anzac.edu.au. Otherwise you can put your details into the form at https://goo.gl/forms/P7uipDaan5NgBfMn2 and the study coordinator will contact you.

Posted in Andrology Australia, Clinical management, Community health, Knowledge exchange, Research and Evaluation |

Men’s views of prostate cancer diagnosis and care

Data from the Victorian Prostate Cancer Registry showed differences in care and poorer rates of survival for men diagnosed with prostate cancer in one Victorian regional area compared with men in metropolitan Melbourne.

To gain an understanding of the reasons behind these regional differences, the experiences and perceptions of men with prostate cancer have been explored in a qualitative study recently published in BMC Cancer.

Comparisons between responses of men from regional and metropolitan areas related mostly to the more limited supportive care available in regional areas. From a more general perspective, it was evident that every aspect of prostate cancer care would benefit from attention, from making efforts to publicise the need for men to check prostate health, to treatment, and supporting men in the years after treatment.

Read more in our journal article reviews.

Posted in Knowledge exchange, Prostate cancer, Research and Evaluation |

It’s Fertility Week!

Fertility Week (15-21 October) is a good time to think about improving your chances of having a baby.

This year Fertility Week fights chemicals in the home that may reduce your chances of becoming pregnant and having a healthy baby.

A particular group of chemicals called endocrine disrupting chemicals (EDCs) can reduce sperm and egg quality and the chance of becoming pregnant. These chemicals can be found in products we use every day around the house.

See the Fertility Week webpage and other important fertility information from Your Fertility to find out more about how you can reduce your exposure to EDCs and increase your chances of pregnancy.

Your Fertility is brought to you by the Fertility Coalition: the Victorian Assisted Reproductive Treatment Authority (VARTA), Andrology Australia, Jean Hailes Research Unit and The Robinson Research Institute.

Posted in Fertility, Health promotion |

Reminder that testicular cancer is a young man’s cancer

A recent news item about a young footballer diagnosed with testicular cancer is a reminder that this is the second most common cancer in men aged 18 to 39.

It’s a good idea for all young men to perform regular testicular self-examination so that any lumps or swelling in the testes can be checked out by a doctor. Most lumps will not be cancer but are more likely to be a less serious problem.

If testicular cancer is found, the good news is that it is very treatable and the cure rate is very high – 98%.

See the Andrology Australia website for more information about testicular cancer and testicular self-examination.

Posted in Adolescent and Young Adult Males, Health promotion, Testicular cancer |

Trial shows long-term mortality for localised prostate cancer is low even if not treated with surgery

A previous shorter follow-up of the PIVOT trial found no significant difference in mortality between men who underwent surgery for localised prostate cancer and those treated with observation only.

This finding was confirmed in a longer term follow-up (up to 20 years) of the trial, which also assessed non-fatal health outcomes.

The study was recently published in the New England Journal of Medicine reported that after almost 20 years follow-up, mortality amongst men with low-risk prostate cancer was low and not significantly different between those treated with surgery and those treated with observation only.

Patient-reported outcomes of urinary incontinence and erectile/sexual dysfunction were higher amongst those undergoing surgery after 10 years but other patient-reported outcomes were not different between groups in the longer term.

Read more in our journal article reviews.

Posted in Knowledge exchange, Prostate cancer, Prostate disease, Research and Evaluation |

Step into spring with the The Healthy Male newsletter!

The Healthy Male, Spring issue


Issue 64 of The Healthy Male newsletter is out now. Read about simple steps you can take to protect your fertility in the lead-up to Fertility Week 2017, plus a host of other features in the Spring edition.

Download The Healthy Male

We are still seeking feedback from readers on our education and health promotion resources. Please go to our short online survey. It should take only 5-10 minutes!


Continue reading

Posted in Andrology Australia, Newsletter, Uncategorized |

Andrology Australia announces a new CEO

Andrology Australia is very pleased to announce that a new Chief Executive Officer has recently been appointed to lead Andrology Australia.

Mr Simon von Saldern comes to us with a great deal of experience and enthusiasm to lead the project over the coming years. Before coming to Andrology Australia Simon was General Manager Development & Business Services at MOVE muscle, bone & joint health (formerly Arthritis & Osteoporosis Victoria).

At MOVE, Simon was instrumental in the successful transition of the organisation to a new structure and brand to better reflect the needs of people with arthritis and osteoporosis.

This experience and Simon’s previous roles in community and not-for-profit organisations will be invaluable for leading Andrology Australia into the future as we embrace new challenges and a changing health environment.

Look out for a feature from Simon on his vision for Andrology Australia in the Summer edition of our newsletter The Healthy Male.

Posted in Andrology Australia |
Website by Essendon Creative